(MedPage Today) -- Oral semaglutide (Rybelsus) protected against heart failure events in type 2 diabetes patients with a history of ...
(MedPage Today) -- Note that some links may require registration or subscription. The United Kingdom's Medicines and Healthcare Products Regulatory ...
(MedPage Today) -- GLP-1 receptor agonists and SGLT2 inhibitors were associated with lower risks for liver-related events and hepatocellular carcinoma ...
(MedPage Today) -- Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more weight if they were also ...
(MedPage Today) -- LAS VEGAS -- GLP-1-based therapies may offer benefits in inflammatory bowel disease (IBD) that extend beyond their ...
(MedPage Today) -- Meals and snacks with "GLP-1 Friendly" labels on the packaging are becoming more common in U.S. supermarkets ...
(MedPage Today) -- SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower ...
(MedPage Today) -- Note that some links may require registration or subscription. Silintan capsules, a dietary supplement marketed for joint ...
(MedPage Today) -- Note that some links may require registration or subscription. Doctors debunked five women's health myths on mammograms, ...
(MedPage Today) -- SAN FRANCISCO -- Patients with a history of GLP-1 receptor agonist treatment had a significantly lower risk ...
PickByDoc is an independent medical news and health awareness platform that curates health-related news, research updates, and public health information from trusted national and international sources for educational purposes only.
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.